Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    Tregs | Diabetes
Show Display Options
Rank Status Study
1 Active, not recruiting T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
2 Recruiting Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Umbilical Cord Blood Regulatory T cells Therapy;   Drug: Insulin
3 Recruiting T1DM Immunotherapy Using Polyclonal Tregs + IL-2
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Treg+IL-2
4 Active, not recruiting Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin
5 Completed Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin (Proleukin)
6 Withdrawn Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)
Condition: Autoimmune Diabetes
Intervention:
7 Active, not recruiting Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Dose D1 of interleukin-2;   Drug: placebo;   Drug: Dose D2 of Interleukin-2;   Drug: Dose D3 of interleukin-2
8 Completed Dose-effect Relationship of Low-dose IL-2 in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin
9 Recruiting Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
Condition: Diabetes Mellitus
Interventions: Biological: CLBS03 Low Dose;   Biological: CLBS03 High Dose;   Biological: Placebo
10 Unknown  The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: blood drawing
11 Recruiting Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: rhIL-2;   Drug: Placebo
12 Unknown  Study of Immune Response in Obesity and Type 2 Diabetes
Conditions: Obesity;   Type 2 Diabetes;   Healthy Volunteers
Intervention: Other: Blood samples
13 Completed Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Cholecalciferol
14 Recruiting Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
Conditions: Diabetes Mellitus;   Malignant Neoplasm
Interventions: Procedure: assessment of therapy complications;   Other: laboratory biomarker analysis
15 Completed Stem Cell Educator Therapy in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Device: Stem Cell Educator
16 Completed Neulasta in Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Neulasta (Pegylated);   Drug: Placebo;   Dietary Supplement: Mixed Meal Tolerance Test (MMTT);   Other: Blood test;   Other: DNA Test
17 Not yet recruiting Diabetes Islet Preservation Immune Treatment
Conditions: Diabetes Mellitus, Type 1;   Hypoglycemia;   Autoimmune Diseases;   Diabetes Mellitus
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Placebo;   Drug: Pegylated GCSF;   Drug: Interleukin 2;   Drug: Etanercept;   Drug: Exenatide
18 Recruiting Pre-POINT-Early Study
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Oral Insulin;   Drug: Placebo
19 Recruiting Fr1da Insulin Intervention
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Oral Insulin;   Other: Placebo
20 Unknown  Can Gluten-free Diet Prevent the Destruction of Beta-cells During Remission?
Condition: Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Glutenfree diet

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.